Recurrent non-hepatic and de novo malignancies after liver transplantation

Ashokkumar Jain, Zakiyah Kadry, Stephanie L. Buchman, Ali Riaz Shah

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

This chapter consists of two parts: first, recurrence of non-hepatic malignancy which liver transplant (LTx) recipients had prior to or at the time of transplant, and second, de novo malignancy which recipients did not have prior to transplant. The recurrence rate of malignancy post-LTx is low. In four studies consisting of 3718 LTx recipients, 108 had malignancies prior to LTx; seven of them recurred post-LTx. 17 LTx patients had myeloproliferative disorders at the time of transplant; one had a recurrence. Post-LTx recurrence for neuroendocrine tumor is high; however, transplant is only performed in highly selected cases. For epidermal, skin cancer, recurrence is frequent. De novo malignancy is the commonest cause of death for adults post-LTx in long term. Since 1998, studies are reported with standard incidence ratio (SIR), where patients' age, gender, and length of follow-up (total person-years calculated by adding survival of each patient) are compared with epidemiological data for each cancer type. This method provides the precise incidence of cancer post-LTx compared to general population. Rates of malignancy increase in proportion to age at transplant and length of follow-up. Skin cancer is the commonest malignancy post-LTx. Certain risk factors for post-transplant de novo cancers are identified: ethanol-induced cirrhosis, smoking (oropharyngeal, lung, esophageal), Barrett’s esophagus (esophageal), and primary sclerosing cholangitis with inflammatory bowel disease (colorectal). The rates of gynecological and breast cancers post-LTx are lower than general population in most studies. There are geographical differences; gastrointestinal cancers in Korea and renal cell carcinomas in Netherlands and Taiwan have higher rates.

Original languageEnglish (US)
Title of host publicationDisease Recurrence After Liver Transplantation
Subtitle of host publicationNatural History, Treatment and Survival
PublisherSpringer New York
Pages215-231
Number of pages17
ISBN (Electronic)9781493929474
ISBN (Print)9781493929467
DOIs
StatePublished - Jan 1 2015

Fingerprint

Liver Transplantation
Neoplasms
Transplants
Recurrence
Skin Neoplasms
Myeloproliferative Disorders
Sclerosing Cholangitis
Gastrointestinal Neoplasms
Barrett Esophagus
Neuroendocrine Tumors
Incidence
Korea
Taiwan
Inflammatory Bowel Diseases
Renal Cell Carcinoma
Netherlands
Population
Cause of Death
Fibrosis
Ethanol

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Jain, A., Kadry, Z., Buchman, S. L., & Shah, A. R. (2015). Recurrent non-hepatic and de novo malignancies after liver transplantation. In Disease Recurrence After Liver Transplantation: Natural History, Treatment and Survival (pp. 215-231). Springer New York. https://doi.org/10.1007/978-1-4939-2947-4_15
Jain, Ashokkumar ; Kadry, Zakiyah ; Buchman, Stephanie L. ; Shah, Ali Riaz. / Recurrent non-hepatic and de novo malignancies after liver transplantation. Disease Recurrence After Liver Transplantation: Natural History, Treatment and Survival. Springer New York, 2015. pp. 215-231
@inbook{1a3a18ca7aca4354b6f1e2220a9766bb,
title = "Recurrent non-hepatic and de novo malignancies after liver transplantation",
abstract = "This chapter consists of two parts: first, recurrence of non-hepatic malignancy which liver transplant (LTx) recipients had prior to or at the time of transplant, and second, de novo malignancy which recipients did not have prior to transplant. The recurrence rate of malignancy post-LTx is low. In four studies consisting of 3718 LTx recipients, 108 had malignancies prior to LTx; seven of them recurred post-LTx. 17 LTx patients had myeloproliferative disorders at the time of transplant; one had a recurrence. Post-LTx recurrence for neuroendocrine tumor is high; however, transplant is only performed in highly selected cases. For epidermal, skin cancer, recurrence is frequent. De novo malignancy is the commonest cause of death for adults post-LTx in long term. Since 1998, studies are reported with standard incidence ratio (SIR), where patients' age, gender, and length of follow-up (total person-years calculated by adding survival of each patient) are compared with epidemiological data for each cancer type. This method provides the precise incidence of cancer post-LTx compared to general population. Rates of malignancy increase in proportion to age at transplant and length of follow-up. Skin cancer is the commonest malignancy post-LTx. Certain risk factors for post-transplant de novo cancers are identified: ethanol-induced cirrhosis, smoking (oropharyngeal, lung, esophageal), Barrett’s esophagus (esophageal), and primary sclerosing cholangitis with inflammatory bowel disease (colorectal). The rates of gynecological and breast cancers post-LTx are lower than general population in most studies. There are geographical differences; gastrointestinal cancers in Korea and renal cell carcinomas in Netherlands and Taiwan have higher rates.",
author = "Ashokkumar Jain and Zakiyah Kadry and Buchman, {Stephanie L.} and Shah, {Ali Riaz}",
year = "2015",
month = "1",
day = "1",
doi = "10.1007/978-1-4939-2947-4_15",
language = "English (US)",
isbn = "9781493929467",
pages = "215--231",
booktitle = "Disease Recurrence After Liver Transplantation",
publisher = "Springer New York",
address = "United States",

}

Jain, A, Kadry, Z, Buchman, SL & Shah, AR 2015, Recurrent non-hepatic and de novo malignancies after liver transplantation. in Disease Recurrence After Liver Transplantation: Natural History, Treatment and Survival. Springer New York, pp. 215-231. https://doi.org/10.1007/978-1-4939-2947-4_15

Recurrent non-hepatic and de novo malignancies after liver transplantation. / Jain, Ashokkumar; Kadry, Zakiyah; Buchman, Stephanie L.; Shah, Ali Riaz.

Disease Recurrence After Liver Transplantation: Natural History, Treatment and Survival. Springer New York, 2015. p. 215-231.

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - Recurrent non-hepatic and de novo malignancies after liver transplantation

AU - Jain, Ashokkumar

AU - Kadry, Zakiyah

AU - Buchman, Stephanie L.

AU - Shah, Ali Riaz

PY - 2015/1/1

Y1 - 2015/1/1

N2 - This chapter consists of two parts: first, recurrence of non-hepatic malignancy which liver transplant (LTx) recipients had prior to or at the time of transplant, and second, de novo malignancy which recipients did not have prior to transplant. The recurrence rate of malignancy post-LTx is low. In four studies consisting of 3718 LTx recipients, 108 had malignancies prior to LTx; seven of them recurred post-LTx. 17 LTx patients had myeloproliferative disorders at the time of transplant; one had a recurrence. Post-LTx recurrence for neuroendocrine tumor is high; however, transplant is only performed in highly selected cases. For epidermal, skin cancer, recurrence is frequent. De novo malignancy is the commonest cause of death for adults post-LTx in long term. Since 1998, studies are reported with standard incidence ratio (SIR), where patients' age, gender, and length of follow-up (total person-years calculated by adding survival of each patient) are compared with epidemiological data for each cancer type. This method provides the precise incidence of cancer post-LTx compared to general population. Rates of malignancy increase in proportion to age at transplant and length of follow-up. Skin cancer is the commonest malignancy post-LTx. Certain risk factors for post-transplant de novo cancers are identified: ethanol-induced cirrhosis, smoking (oropharyngeal, lung, esophageal), Barrett’s esophagus (esophageal), and primary sclerosing cholangitis with inflammatory bowel disease (colorectal). The rates of gynecological and breast cancers post-LTx are lower than general population in most studies. There are geographical differences; gastrointestinal cancers in Korea and renal cell carcinomas in Netherlands and Taiwan have higher rates.

AB - This chapter consists of two parts: first, recurrence of non-hepatic malignancy which liver transplant (LTx) recipients had prior to or at the time of transplant, and second, de novo malignancy which recipients did not have prior to transplant. The recurrence rate of malignancy post-LTx is low. In four studies consisting of 3718 LTx recipients, 108 had malignancies prior to LTx; seven of them recurred post-LTx. 17 LTx patients had myeloproliferative disorders at the time of transplant; one had a recurrence. Post-LTx recurrence for neuroendocrine tumor is high; however, transplant is only performed in highly selected cases. For epidermal, skin cancer, recurrence is frequent. De novo malignancy is the commonest cause of death for adults post-LTx in long term. Since 1998, studies are reported with standard incidence ratio (SIR), where patients' age, gender, and length of follow-up (total person-years calculated by adding survival of each patient) are compared with epidemiological data for each cancer type. This method provides the precise incidence of cancer post-LTx compared to general population. Rates of malignancy increase in proportion to age at transplant and length of follow-up. Skin cancer is the commonest malignancy post-LTx. Certain risk factors for post-transplant de novo cancers are identified: ethanol-induced cirrhosis, smoking (oropharyngeal, lung, esophageal), Barrett’s esophagus (esophageal), and primary sclerosing cholangitis with inflammatory bowel disease (colorectal). The rates of gynecological and breast cancers post-LTx are lower than general population in most studies. There are geographical differences; gastrointestinal cancers in Korea and renal cell carcinomas in Netherlands and Taiwan have higher rates.

UR - http://www.scopus.com/inward/record.url?scp=84957675642&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84957675642&partnerID=8YFLogxK

U2 - 10.1007/978-1-4939-2947-4_15

DO - 10.1007/978-1-4939-2947-4_15

M3 - Chapter

AN - SCOPUS:84957675642

SN - 9781493929467

SP - 215

EP - 231

BT - Disease Recurrence After Liver Transplantation

PB - Springer New York

ER -

Jain A, Kadry Z, Buchman SL, Shah AR. Recurrent non-hepatic and de novo malignancies after liver transplantation. In Disease Recurrence After Liver Transplantation: Natural History, Treatment and Survival. Springer New York. 2015. p. 215-231 https://doi.org/10.1007/978-1-4939-2947-4_15